Arteris (AIP) Q2 2026 earnings review
Relentless Top-Line Acceleration vs. Widening Operating Losses
Arteris delivered its fifth consecutive quarter of accelerating revenue growth, surging 46% YoY to a record $24.1M. The shift toward AI compute and chiplet architectures is supercharging demand, pushing ACV plus royalties up 44% to $99.5M. However, the costs of this hyper-growth are materializing. Despite the massive revenue beat and a surprising $8.6M positive Free Cash Flow quarter, management quietly worsened its full-year Non-GAAP operating loss guidance to $7.0M-$10.0M (from $4.5M-$8.5M in Q1). Investors are witnessing a flawless top-line execution story, but the timeline to structural profitability is getting cloudier just as a new CFO takes the helm.
🐂 Bull Case
The majority of new Arteris designs now incorporate AI compute. TTM confirmed design starts accelerated 21%, indicating that the front end of the sales funnel remains incredibly robust.
Trailing-twelve-months variable royalties surged 65% YoY to $8.6M. As older automotive and enterprise design wins transition into high-volume production, this high-margin revenue acts as a powerful financial tailwind.
🐻 Bear Case
Despite a revenue guide raise, FY26 Non-GAAP operating loss guidance was widened by $2.5M at the midpoint. Expenses are creeping up faster than anticipated, complicating the previously stated goal of reaching profitability by Q4 2026.
Incoming CFO Saurabh Sinha takes over on September 8 from retiring Nick Hawkins. A leadership change during a critical phase of heavy spending and aggressive M&A integration (Cycuity/Semifore) introduces execution risk.
⚖️ Verdict: 🟢
Bullish. The top-line momentum is undeniable and rare. While the worsening operating loss guidance is a red flag that demands scrutiny, Arteris is successfully embedding itself into the fundamental architecture of the AI and chiplet boom.
Key Themes
AI & Enterprise Computing Driving the Engine
Enterprise computing now averages 29% of ACV plus royalties over the past four quarters. Arteris is successfully capitalizing on the AI infrastructure boom, winning placements in complex data center hardware. A standout win this quarter is Speedata, which is deploying Arteris in its purpose-built Analytics Processing Unit (APU) for high-volume data center analytics. This represents an accelerating trend of hyperscalers and AI chipmakers prioritizing specialized interconnect IP.
Royalty Conversions Accelerating
The lag between design wins and royalty generation (historically 3-6 years) is finally closing in a meaningful way. Trailing-twelve-months variable royalties hit $8.6M, up 65% YoY. This is a critical driver for gross margin preservation and proves that customers are shipping Arteris-enabled silicon in significant volumes.
The Growth vs. Profitability Disconnect
A stark contradiction emerged this quarter: Management raised FY26 revenue guidance by $4M at the midpoint, yet simultaneously widened the Non-GAAP operating loss guidance from $4.5-$8.5M to $7.0-$10.0M. Q2's Non-GAAP operating loss was $4.6M, a reversal from earlier narrowing trends. This suggests that R&D, sales investments, or integration costs from the Cycuity acquisition are severely eating into the operating leverage management previously touted.
Chinese Automotive Exposure Amid Macro Tensions
Management highlighted new deployments with Li Auto and SiEngine, solidifying Arteris's footprint in China's rapidly advancing new energy vehicle and intelligent cockpit ecosystem. While this acts as a near-term revenue driver, it leaves the company highly exposed to a vulnerable macro environment. Ongoing U.S.-China semiconductor trade restrictions and potential tariffs present a significant, unpredictable risk to this revenue base.
Security Expansion Bearing Fruit
The acquisition of Cycuity/Semifore is starting to pay strategic dividends. Arm explicitly expanded its partnership with Arteris this quarter to license its hardware security assurance technology. Cross-selling security solutions into the existing base of 200+ customers is accelerating ACV expansion and cementing Arteris as a platform rather than a point-solution provider.
Other KPIs
A massive reversing trend. FCF jumped to $8.6M in Q2, compared to negative $2.8M in 25Q2 and negative $7.4M in 26Q1. This was primarily driven by strong cash collections and favorable working capital timing (Accounts Receivable decreased from $19.2M to $15.2M). Note: Management previously stated they would no longer provide forward FCF guidance due to booking lumpiness, making this metric highly volatile quarter-to-quarter.
Accelerating. RPO grew 36% YoY, a step up from the 33% growth seen in 26Q1. This provides exceptional forward visibility and heavily de-risks the raised FY26 revenue guidance.
Guidance
Implies a deceleration in YoY growth to approximately 41% at the midpoint, compared to 46% in Q2. However, it still represents a sequentially stable and exceptionally strong growth rate driven by AI design starts.
Accelerating expectations. Management raised the full-year outlook from the prior $91.0-$95.0M range. The midpoint implies ~36% YoY annual growth, signaling supreme confidence in the back-half deployment schedule.
Reversing/Deteriorating. In Q1, management guided this metric to a loss of $4.5-$8.5M. Widening the loss guidance despite higher revenue implies a significant increase in projected operating expenses, likely tied to R&D for AI multi-die solutions or post-acquisition integration costs.
Key Questions
The Profitability Target
You previously indicated an expectation to achieve Non-GAAP operating profitability as early as Q4 2026. With the full-year operating loss guidance widening by $2.5M at the midpoint, is that Q4 milestone still intact, or have investment requirements pushed that timeline out?
Free Cash Flow Volatility
Q2 generated an impressive $8.6M in Free Cash Flow, primarily aided by working capital movements and AR drawdown. Should we expect cash flow to normalize back toward negative territory in Q3, or has the business reached a structural cash-generation inflection point?
China Auto Market Exposure
You highlighted strong wins with Li Auto and SiEngine this quarter. How are you navigating the geopolitical risks and evolving export control restrictions regarding advanced automotive and intelligent cockpit silicon in China?